Primary Cardiac Malignant Lymphoma: Survival for 13 Years After Surgical Resection and Adjuvant Chemotherapy

We report a patient who has survived for 13 years after surgical resection of a cardiac malignant lymphoma. A 73-year-old woman underwent partial resection of a tumor occluding the tricuspid valve, which arose from the right atrium. The pathologic diagnosis was diffuse large B cell lymphoma. She was...

Full description

Saved in:
Bibliographic Details
Published inThe Annals of thoracic surgery Vol. 99; no. 3; pp. 1060 - 1062
Main Authors Gyoten, Takayuki, MD, Doi, Toshio, MD, Nagura, Saori, MD, Yamashita, Akio, MD, Fukahara, Kazuaki, MD, Kotoh, Keiju, MD, Yoshimura, Naoki, MD
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 01.03.2015
Subjects
Aged
Cardiothoracic Surgery
Chemotherapy, Adjuvant
Disease-Free Survival
Female
Heart Neoplasms - drug therapy
Heart Neoplasms - surgery
Humans
Lymphoma, Large B-Cell, Diffuse - drug therapy
Lymphoma, Large B-Cell, Diffuse - surgery
Surgery
Time Factors
18
Online AccessGet full text

Cover

More Information
Summary:We report a patient who has survived for 13 years after surgical resection of a cardiac malignant lymphoma. A 73-year-old woman underwent partial resection of a tumor occluding the tricuspid valve, which arose from the right atrium. The pathologic diagnosis was diffuse large B cell lymphoma. She was treated with adjuvant chemotherapy for 6 months postoperatively. Since then, she has shown no evidence of recurrence, without any further treatment. To our knowledge, this is the longest surviving case of cardiac malignant lymphoma. The therapeutic strategy for this malignant cardiac tumor is discussed briefly.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0003-4975
1552-6259
DOI:10.1016/j.athoracsur.2014.05.074